Two Sigma Investments’s GSK GSK Stock Holding History

Two Sigma Investments’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$221K	Buy	+4,000	New	+$217K	﹤0.01%	4245

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Two Sigma Investments's GSK Position: Q1 2026 in Review

Two Sigma Investments sold out of GSK (GSK) in Q1 2026, closing a stake of 36,300 shares — an estimated $1.97M sold.

Two Sigma Investments first reported a position in GSK in Q2 2013 and held it in 44 quarters. The position peaked at $210M in Q3 2022. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

Two Sigma Investments reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
Two Sigma Investments sold 36,300 GSK shares in Q1 2026, an estimated $1.97M.
Two Sigma Investments first reported a position in GSK in Q2 2013 and held it in 44 quarters.
Two Sigma Investments's GSK position peaked at $210M in Q3 2022.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.